Skip to main content
SpringerLink
Log in

Positive FDA review likely to boost irinotecan sales

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Positive FDA review likely to boost irinotecan sales. Pharmacoecon. Outcomes News 350, 11 (2002). https://doi.org/10.1007/BF03278709

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03278709

Keywords

Search

Navigation